YTHDF1与SQLE之间存在一条表观转录组-代谢通路,该通路通过调控SQLE的表达,进而影响乳腺癌干细胞的自我更新能力。
An epitranscriptomic-metabolic axis from YTHDF1 to SQLE drives breast cancer stemness
Hong Zhipeng, Jiang Yu, Niu Yingjie, Dong Mengru, Du Xianqiang, Chen Yanzhen, Chen Debo
Journal:Communications Biology
IF:5.8
DOI:10.1038/s42003-026-10863-z
PMID:
Published:2026-09-10
research field:表观转录组学代谢癌症生物学干细胞研究分子肿瘤学
Abstract
The metabolic plasticity of breast cancer stem cells (BCSCs) drives tumor propagation and therapeutic resistance, yet the molecular circuits governing these states remain incompletely understood. Here, we identify a pivotal epitranscriptomic-metabolic axis implicated in BCSCs maintenance. The N6-methyladenosine (m6A) reader YTHDF1 post-transcriptionally controls squalene epoxidase (SQLE), a rate-limiting enzyme in cholesterol biosynthesis. Clinically, high YTHDF1 / SQLE co-expression is associated with poor patient survival in both our cohort and the TCGA-BRCA dataset. Mechanistically, YTHDF1 directly binds m6A-modified SQLE mRNA at the A906 site, as demonstrated by site-specific mutagenesis and luciferase reporter assays. Polysome profiling reveals that YTHDF1 enhances SQLE translation efficiency beyond mRNA stabilization. SQLE upregulation drives cholesterol accumulation and aldehyde dehydrogenase (ALDH) activity, fostering metabolic programs associated with BCSC self-renewal, as confirmed by cholesterol rescue experiments. Genetic depletion of either YTHDF1 or SQLE impairs core BCSC properties, significantly impairs secondary mammosphere formation, reduces expression of cancer stem cell markers Oct-4 and Sox-2 in vivo, and suppresses tumor growth consistent with impaired tumor-initiating capacity in xenograft models. Our findings illuminate a metabolic-epigenetic vulnerability in breast cancer, providing a rationale for targeting the YTHDF1-SQLE axis to eliminate BCSCs.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


